The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: Outcomes in patients (pts) with low- and high-risk disease.
 
Mustafa Ozguroglu
No Relationships to Disclose
 
Simon Chowdhury
Honoraria - Clovis Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer
Speakers' Bureau - Pfizer
Research Funding - Sanofi/Aventis (Inst)
 
Anders Bjartell
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Bayer; Ferring
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ferring (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ferring; Janssen-Cilag
 
Hirotsugu Uemura
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb Japan; Janssen; MSD; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Ono Pharmaceutical; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Byung Ha Chung
Honoraria - Astellas Pharma; Ipsen; JW Pharmaceutical; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Astellas Pharma; Handok; Ipsen; Janssen; JW Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst); Myovant Sciences (Inst); Pfizer (Inst); Roche (Inst)
 
Neeraj Agarwal
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Bristol-Myers Squibb; Exelixis; Foundation Medicine; Foundation One Inc; Lilly; Lilly; Medivation/Astellas; Nektar; Pfizer; Pharmacyclics
Research Funding - Active Biotech (Inst); Amgen (Inst); AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Axel Stuart Merseburger
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Ipsen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen-Cilag (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen-Cilag
 
Álvaro Juárez Soto
Consulting or Advisory Role - Bayer; Ipsen; Janssen; Pfizer
Research Funding - Bayer; Janssen Research & Development
 
Angela Lopez-Gitlitz
No Relationships to Disclose
 
Amitabha Bhaumik
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Allergan; Allergan (I)
 
Julie S. Larsen
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Sharon Anne McCarthy
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Kim N. Chi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; ESSA; Janssen; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)